Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2017 Mar;15(3):325–334. doi: 10.1016/j.cgh.2016.10.022

Table 2.

Summary of FLIP methods and results of studies evaluating EGJ-distensibility in asymptomatic controls.

Author,
year
N 1FLIP
length,
cm
IP channel
spacing,
mm
2Test setting,
sedation
Placement Pressure
zero
Fill
volume,
ml
3EGJ-DI,
mm2/mmHg
Comparator
group

Beaumont, 200935 10 6.4 4 awake oral gastric 10–60 3.7 +/− 0.9 Barrett’s, post-ablation

Kwiatek, 20104 20 6.4 4 Endoscopy, Conscious Oral Gastric 10 3.2 (2.3 – 6.7) GERD
20 2.2 (1.2 – 6.5)
30 4.2 (1.7 – 10.4)
40 7.3 (3.8 – 11.4)

Kwiatek, 201113 15 8 5 Endoscopy, Conscious Oral NR 20 0.9 (0.3 – 1.4) EoE
30 0.8 (0.4 – 2.8)

Rohof, 20125 15 6.4 4 Awake Nasal Atm 50 6.3 +/− 0.7 Achalasia

Nathanson, 201236 50 8 5 Intra-operative, General anesthesia Oral Gastric 30 1.1 (0.7 – 1.6) --
40 1.2 (0.83 – 2.2)

Tucker, 20137 22 6.4 4 Endoscopy, Conscious Oral NR 20 4.0 (2.4 – 7.5) GERD
30 6.1 (4.3 – 8.0)

Rieder, 201315 4 8 5 Awake Oral NR 30 2.5 (2.0 – 6.3) Achalasia
40 2.7 (2.4 – 8.3)

Fukazawa, 201437 9 8 5 Awake Nasal Atm 20 2.9 +/− (0.6) Intra-subject following mosapride
40 7.1 +/− (0.9)
50 8.2 +/− (0.8)

Lottrup, 201538 10 8 5 Awake Oral Atm 20 1.9 +/− 0.5 GERD, hiatal hernia
30 2.8 +/− 0.6
40 3.8 +/− 0.9
50 3.9 +/− 0.7

Carlson, 201511 10 16 10 Endoscopy, Conscious Oral Atm 50 7.1 (3.8 – 8.9) Achalasia
60 6.2 (4.6 – 8.1)

Mikami, 201639 9 6.4 4 Awake Nasal Atm 20 1.8 +/− (0.2) Intra-subject following metoclopramide
30 3.5 +/− (0.6)
40 4.5 +/− (0.5)
1

Length of the cylindrical, measurement segment.

2

Conscious sedation with midazolam and fentanyl or pethidine.

3

Results extrapolated from figures if not directly reported and represented as median (inter-quartile range) or mean +/− SD (SE).

IP – impedance planimetry. NR – not reported. Atm – atmospheric.

*

Courtesy of Dustin Carlson